SGMTSagimet Biosciences Inc.
$8.91+21% 1Y
$8.91
$4.5552 weeks$11.16
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +23% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SGMT is trading
Sagimet Biosciences Inc. is +21% over the past year while the S&P 500 is +18%: 3.2 points ahead of the market.
+21%
1-year return · S&P 500 +18%
- vs 200-day average
- +23%
vs 200-day average · a clear uptrend
- RSI (14)
- 31
RSI (14) · neutral
- Below its 52-week high
- 20%
Below its 52-week high
Details›
- Last close2026-10-08
- $8.91
- 1 monthS&P 500 +1.6%
- −18%
- 1 yearS&P 500 +18%
- +21%
- vs 50-day average$9.88
- −9.8%
- 52-week high
- $11.16
- 52-week low
- $4.55
- Annualised volatility
- 101%
| Year | Return |
|---|---|
| 2026 (year to date) | +51% |
| 2025 | +32% |
| 2024 | −17% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 3 | 1 of 3 | +23% |
| Feb | 3 | 1 of 3 | −17% |
| Mar | 3 | 0 of 3 | −11% |
| Apr | 3 | 2 of 3 | +10% |
| May | 3 | 2 of 3 | +10% |
| Jun | 3 | 2 of 3 | +28% |
| Jul | 3 | 1 of 3 | +1.4% |
| Aug | 4 | 1 of 4 | −0.43% |
| Sep | 4 | 0 of 4 | −12% |
| Oct | 4 | 2 of 4 | +10% |
| Nov | 3 | 2 of 3 | −0.13% |
| Dec | 3 | 1 of 3 | +0.99% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.